Skip to main content
Log in

Regulation of slow calcium channels of myocardial cells and vascular smooth muscle cells by cyclic nucleotides and phosphorylation

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The slow Ca2+ channels (L-type) of the heart are stimulated by cAMP. Elevation of cAMP produces a very rapid increase in number of slow channels available for voltage activation during excitation. The probability of a Ca2+ channel opening and the mean open time of the channel are increased. Therefore, any agent that increases the cAMP level of the myocardial cell will tend to potentiate ICa, Ca2+ influx, and contraction. The action of cAMP is mediated by PK-A and phosphorylation of the slow Ca2+ channel protein or an associated regulatory protein (stimulatory type). The myocardial slow Ca2+ channels are also rogulated by cGMP, in a manner that is opposite orantagonistic to that of cAMP. We have demonstrated this at both the macroscople level (whole-cell voltage clamp) and the single-channel level. The effect of cGMP is mediated by PK-G and phosphorylation of a protein, as for example, a regulatory protein (inhibitory-type) associated with the Ca2+ channel. Introduction of PK-G intracellularly causes a relatively rapid inhibition of ICa(L) in both chick and rat heart cells. Such inhibition occurs for both the basal and stimulated ICa(L). In addition, the cGMP/PK-G system was reported to stimulate a phosphatase that dephosphorylates the Ca2+ channel. In addition to the slower indirect pathway—exerted via cAMP/PK-A—there is a faster more-direct pathway for ICa(L) stimulation by the β-adrenergic receptor. This latter pathway involves direct modulation of the channel activity by the alpha subunit (αs*) of the Gs-protein. In vascular smooth muscle cells the two pathways (direct and indirect) also appear to be present, although the indirect pathway producesinhibition of ICa(L). PK-C and calmodulin-PK also may play roles in regulation of the myocardial slow Ca2+ channels. Both of these protein kinases stimulate the activity of these channels. Thus, it appears that the slow Ca2+ channel is a complex structure, including perhaps several associated regulatory proteins, which can be regulated by a number of factors intrinsic and extrinsic to the cell, and thereby control can be exercised over the force of contraction of the heart.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Llinas R, Sugimori D, Hillman E, Cherksey B: Distribution and functional significance of the P-type, voltage-dependent Ca2+ channels in the mammalian central nervous system. TINS 15:351–355, 1992

    PubMed  Google Scholar 

  2. Mintz IM, Venema VJ, Swiderek KM, Lee TD, Bean BP, Adams ME: P-type calcium channels blocked by the spider toxin omega-Aga-IVA. Nature 355:827–829, 1992

    PubMed  Google Scholar 

  3. Nowycky MC, Fox AP, Tsien RW: Three types of neuronal calcium channels with different calcium agonist sensítivity. Nature 316:440–443, 1985

    PubMed  Google Scholar 

  4. Tohse N, Masuda H, Sperelakis N: Novel isoform of Ca2+ channel in rat fetal cardiomyocytes. J Physiol (London) 451:295–306, 1992

    Google Scholar 

  5. Tohse N, Sperelakis N: Long-lasting openings of single slow (L-type) Ca2+ channels in chick embryonic heart cells. Am J Physiol 259:H639-H642, 1990

    PubMed  Google Scholar 

  6. Masuda H, Sperelakis N: Unpublished observations

  7. Tohse N, Meszaros J, Sperelakis N: Developmental changes in long-opening behavior of L-type Ca2+ channels in embryonic chick heart cells. Circ Res 71:376–384, 1992

    PubMed  Google Scholar 

  8. Tohse N, Conforti L, Sperelakis N: Bay K 8644 enhances Ca2+ channel activities in embryonic chick heart cells without prolongation of open times. Eur J Pharmacol 203:307–310, 1991

    PubMed  Google Scholar 

  9. Shigenobu K, Sperelakis N: Ca2+ current channels induced by catechol-amines in chick embryonic hearts whose fast Na+ channels are blocked by tetrodotoxin or elevated K+. Circ Res 31:932–952, 1972

    PubMed  Google Scholar 

  10. Tsien RW, Giles W, Greengard P: Cyclic AMP mediates the action of adrenaline on the action potential plateau of cardiac Purkinje fibers. Nature 240:181–183, 1972

    Google Scholar 

  11. Reuter H, Scholz H: The regulation of the calcium conductance of cardiac muscle by adrenaline. J Physiol (London) 264:49–62, 1977

    Google Scholar 

  12. Vogel S, Sperelakis N: Induction of slow action potentials microiontophoresis of cyclic AMP into heart cells. J Mol Cell Cardiol 13:51–64, 1981

    PubMed  Google Scholar 

  13. Li T, Sperelakis N: Stimulation of slow action potentials in guinea pig papillary muscle cells by intracellular injection of cAMP, Gpp(NH)p, and cholera toxin. Circ Res 52:111–117, 1983

    PubMed  Google Scholar 

  14. Bkaily G, Sperelakis N: Injection of cyclic GMP into her cells blocks the slow action potentials. Am J Phusiol (Heart Circ Physiol) 248:H745-H749, 1985

    Google Scholar 

  15. Josephson I, Sperelakis N: 5′-Guanylimidodiphosphate stimulation of slow Ca2+ current in myocardial cells. J Mol Cell Cardiol 10:1157–1166, 1978

    PubMed  Google Scholar 

  16. Irisawa H, Kokobun S: Modulation by intracellular ATP and cyclic AMP of the slow inward current in isolated single ventricular cells of the guineapig. J Physiol 338:321–327, 1983

    PubMed  Google Scholar 

  17. Nargeot J, Nerbonne JM, Engels J, Lester HA: Time course of the increase in the myocardial slow inward current after a photochemically generated concentration jump of intracellular cAMP. Proc Natl Acad Sci 80:2395–2399, 1983

    PubMed  Google Scholar 

  18. Cachelin AB, dePeyer JE, Kokobun S, Reuter H: Ca2+ channel modulation by 8-bromo-cyclic AMP in culture heart cells. Nature 304:462–464, 1983

    PubMed  Google Scholar 

  19. Trautwein W, Hoffman F: Activation of calcium current by injection of cAMP and catalytic subunit of cAMP-dependent protein kinase. Proc Internat Union Physiol Sci 15:75–83, 1983

    Google Scholar 

  20. Bean BP, Nowycky MC, Tsien RW: β-adrenergic modulation of calcium channels in frog ventricular heart cells. Nature 307:371–375, 1984

    PubMed  Google Scholar 

  21. Reuter H, Stevens CF, Tsien RW, Yellen G: Properties of single calcium channels in cardiac cell culture. Nature 297:501–504, 1982

    PubMed  Google Scholar 

  22. Sperelakis N, Schneider J: A metabolic control mechanism for calcium ion influx that may protect the ventricular myocardial cell. Am J Cardiol 37:1079–1085, 1976

    PubMed  Google Scholar 

  23. Vogel S, Sperelakis N, Josephson J, Brooker G: Fluoride stimulation of slow Ca2+ current in cardiac muscle. J Mol Cell Cardiol 9:461–475, 1977

    PubMed  Google Scholar 

  24. Sperelakis N, Tohse N, Ohya Y: Regulation of calcium slow channels in cardiac muscle and vascular smooth muscle. Proceedings of a symposium in Banff, June 27–30, 1991. In: G.B. Frank, C.P. Bianchi and H. Ter Keors (eds). Excitation-Contraction Coupling in Skeletal, Cardiac and Smooth Muscle. Adv Exp Med Biol 311:163–187. Plenum Press, 1992

  25. Osterrieder W, Brum G, Hescheler J, Trautwein W, Flockerzi V, Hofmann F: Injection of subunits of cyclic AMP-depenent protein kinase into cardiac myocytes modulates Ca2+ current. Nature 298:576–578, 1982

    PubMed  Google Scholar 

  26. Haddad G, Sperelakis N, Bkaily G: Regulation of calcium slo channels in myocardial cells by cyclic nucleotides and phosphorylation. Am J Physiol, 1994 (in revision)

  27. Bkaily G, Sperelakis N: Injection of protein kinase inhibitor into cultured heart cells blocks calcium slow channels. Am J Physiol 246:H630-H634, 1984

    PubMed  Google Scholar 

  28. Kameyama M, Hofmann F, Trautwein W: On the mechanism of β-adrenergic regulation of the Ca2+ channel in the guinea-pig heart. Pflugers Arch 405:285–293, 1986

    Google Scholar 

  29. Chad JE, Eckert RJ: An enzymatic mechanism for calcium current inactivation in dialysed Helix neurones. J Physiol 378:31–51, 1986

    PubMed  Google Scholar 

  30. Hescheler J, Kameyama M, Trautwein W, Mieskes G, Soling HD: Regulation of the cardiac calcium channel by protein phosphatases. Eur J Biochem 165:261–266, 1987

    PubMed  Google Scholar 

  31. Hescheler J, Mieskes G, Ruegg JC, Takai A, Trautwein W: Effects of a protein phosphatase inhibitor, okadaic acid, on membrane currents of isolated guinea-pig cardiac myocytes. Pflugers Arch 412:248–252, 1988

    PubMed  Google Scholar 

  32. Reuter H: Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature 301:569–574, 1983

    PubMed  Google Scholar 

  33. Armstrong D, Eckert R: Voltage-activated calcium channels that must be phosphorylated to respond to membrane depolarization. Proc Natl Acad Sci USA 84:2518–2522, 1987

    PubMed  Google Scholar 

  34. Ohya Y, Sperelakis N: Modulation of single slow (L-type) calcium channels by intracellular ATP in vascular smooth muscle cells. Pflugers Arch 414:257–264, 1989

    PubMed  Google Scholar 

  35. Goldberg ND, Haddox MK, Nicol SE, Glass DB, Sanford CH, Kuehl FA Jr, Estensen R: Biological regulation through opposing influences of cyclic GMP and cyclic AMP: The Yin Yang hypothesis. Adv Cyclic Nucleo Res 5:307–330, 1975

    Google Scholar 

  36. Nawrath H: Does cyclic GMP mediate the negative inotropic effect of acetylcholine in the heart? Nature 267:72–74, 1977

    PubMed  Google Scholar 

  37. Kohlhardt M, Haap K: 8-Bromo-guaanosine-3′,5′-monophosphate mimics the effect of acetylcholine on slow response action potential and contractile force in mammalian atrial myocardium. J Molec Cel Cardiol 16: 573–578, 1978

    Google Scholar 

  38. Trautwein W, Taniguchi J, Noma A: The effect of intracellulr cyclic nucleotides and calcium on the action potential and acetylcholine response of isolated cardiac cells. Pflugers Arch 392:307–314, 1982

    PubMed  Google Scholar 

  39. Wahler GM, Sperelakis N: Intracellular injection of cyclic GMP depresses cardiac slow action potentials. J Cyclic Nucleo Prot Phos Res 10:85–95, 1985

    Google Scholar 

  40. Mehegan JP, Muir WW, Unverferth DV, Fertel RH, McGuirk SM: Electrophysiological effects of cyclic GMP on canine cardiac Purkinje fibers. J Cardiovasc Pharmacol 7:30–35, 1985

    PubMed  Google Scholar 

  41. Wahler GM, Rusch NJ, Sperelakis N: 8-bromo-cyclic GMP inhibits the calcium channel current in embryonic chick ventricular myocytes. Can J Physiol Pharm 68:531–534, 1990

    Google Scholar 

  42. Sperelakis N, Xiong Z, Masuda H, Tohse N: Developmental changes and regulation of L-type Ca2+ channels of myocardial cells and vascular smooth muscle cells. In: M. Morad, S. Ebashi, W. Trautwein and Y. Kurachi (eds). Molecular Physiology and Pharmacology of Cardiac Ion Channels and Transporters. Dedicated to Prof. h. Irisawa. 1994 (submitted)

  43. Tohse N, Nakaya H, Takeda Y, Kanno M: Cyclic GMP-medisted inhibition of L-type Ca2+ channel activity by human netriuretic peptide in rabbit heart cells. 1994 (submitted)

  44. Tohse N, Sperelakis N: Cyclic GMP inhibits the activity of single calcium channels in embryonic chick heart cells. Circ Res 69:325–331, 1991

    PubMed  Google Scholar 

  45. Tohse N, Nakaya H, Takeda Y, Kanno M: Inhibitory effect of human atrial natriuretic peptide on cardiac L-type Ca channels. Jpn J Pharmacol 58: 184pp, 1992

  46. Ono K, Fozzard HA, Nanck DA: Mechanism of cAMP-dependent modulation of cardiac sodium channel current kinetics. Circ Res 72:807–815, 1993

    PubMed  Google Scholar 

  47. Ohya Y, Sperelakis N: Tocolytic agents act on calcium channel current in single smooth muscle cells of pregnant rat uterus. J Pharm and Exper Therap 253:580–585, 1990

    Google Scholar 

  48. Inoue Y, Sperelakis N: Gestational change in Na+ and Ca2+ channel current densities in rat myometrial smooth muscle cells. Am J Physiol 260: C658-C663, 1991

    PubMed  Google Scholar 

  49. Kokate TG, Sperelakis N, Heiny J: Stimulation of the slow calcium current in bullfrog skeletal muscle fibers by cAMP and cGMP. Am J Physiol 265:C47-C53, 1993

    PubMed  Google Scholar 

  50. Hartzell HC, Fischmeister R: Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells. Nature 323:273–275, 1986

    PubMed  Google Scholar 

  51. Fischmeister R, Hartzell RC: Cyclic guanosine 3′,5′-monophosphate regulates the calcium current in single cells from frog ventride. J Physiol 387:455–472, 1987

    Google Scholar 

  52. Levi RC, Alloatti G, Fischmeister R: Cyclic GMP regulates the Ca-channel current in guinea pig ventricular myocytes. Pflugers Arch 413:685–687, 1989

    PubMed  Google Scholar 

  53. Mery PF, Lohmann SM, Walter U, Fischmeister R: Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalran cardiac myocytes. Proc Natl Acad Sci 88:1197–1201, 1991

    PubMed  Google Scholar 

  54. Thakkar J, Tang S, Sperelakis N, Wahler G: Inhibition of cardiac slow action potentials by 8-bromo-cyclic GMP occurs independent of changes in cyclic AMP levels. Can J Physiol Pharmacol 66:1092–1095, 1988

    PubMed  Google Scholar 

  55. Haddad Get al. Unpublished data

  56. Cuppoletti J, Thakkar J, Sperelakis N, Wahler G: Cardiac sarcolemmal substrate of the cGMP-dependent protein kinase. Memb Biochem 7:135–142, 1988

    Google Scholar 

  57. George WJ, Polson JB, O'Toole AG, Goldberg ND: Elevation of guanosine 3′,5′-cyclic phosphate in rat heart after perfusion with acetylcholine. Proc Natl Acad Sci 66:398–403, 1970

    PubMed  Google Scholar 

  58. MacLeod KM, Diamond J: Effects of the cyclic GMP lowering agent LY83583 on the interaction of carbachol with forskolin in rabbit isolated cardiac preparations. J Pharmacol Exp Therap 238:313–318, 1986

    Google Scholar 

  59. Wahler GM, Sperelakis N: Cholinergic attenuation of the electrophysiological effects of forskolin. J Cyclic Nucleo Prot Phosph Res 11:1–10, 1986

    Google Scholar 

  60. Ahmad Z, Green FJ, Subuhi HS, Watanabe AM: Purification and characterization of an α-1,2-mannosidase involved in processing asbaragine linked olig saccharides. J Biol Chem 264:3859–3863, 1989

    PubMed  Google Scholar 

  61. hescheler J, Kameyama M, Trautwein W: On the mechanism of muscarinic inhibition of the cardiac Ca current. Pflugers Arch 407:182–189, 1986

    PubMed  Google Scholar 

  62. Ono K, Trautwein W: Potentiation by cyclic GMP of β-adrenergic effect on Ca2+ current in guinea-pig ventricular cells. J Physiol 443:387–404, 1991

    PubMed  Google Scholar 

  63. Freer RJ, Pappano AJ, Peach MJ, Bing KT, McLean MJ, Vogel SM, Sperelakis N: Mechanism of the positive inotropic effect of angiotensin II on isolated cardiac muscle. Circ Res 39:178–183, 1976

    PubMed  Google Scholar 

  64. Bruckner R, Scholz H: Effects of alpha-adrenoceptor stimulation with phenylephrine in the presence of propranolol on force of contraction, slow inward current and cyclic AMP content in the bovine heart. Br J Pharmacol 82:223–232, 1984

    PubMed  Google Scholar 

  65. Dosemeci A, Dhalla RS, Cohen NM, Lederer WJ, Rogers TB: Phorbol ester increases calcium current and stimulates the effects of angiotensin II on cultured neonatal rat heart myocytes. Circ Res 62:347, 1988

    PubMed  Google Scholar 

  66. Tohse N, Kameyama M, Sakiguchi K, Shearman MS, Kanno M: Protein kinase C activation enhances the delayed rectifier K+ current in guineapig heart cells. J Mol Cell Cardiol 22:725–734, 1990

    PubMed  Google Scholar 

  67. Bkaily G, Sperelakis N: Calmodulin is required for a full activation of the calcium slow channels in heart cells. J Cyclic Nucleo Prot Phosph Res 11:25–34, 1986

    Google Scholar 

  68. Xiong Z, Sperelakis N, Fenoglio-Preiser C: Regulation of L-type calcium channels by cyclic nucleotides and phosphorylation in smooth muscle cells from rabbit portal vein. J Vasc Res, 1994 (in press)

  69. Sperelakis N, Ohya Y: Regulation of calcium slow channels in vascular smooth muscle cells. In: N. Sperelakis and H. Kuriyama (eds). Electrophysiology and Ion Channels of Vascular Smooth Muscle and Endothelial Cells. Elsevier Publishers, pp 27–38, 1991

  70. Yatani A, Codina J, Imoto Y, Reeves JP, Birnbaumer L, Brown AM: Direct Regulation of Mammalian Cardisc Calcium Channels by a G Protein. Science 238:1288–1292, 1987

    PubMed  Google Scholar 

  71. Xiong Z, Sperelakis N, Fenoglio-Preiser C: Isoproterenol stimulates the calcium channels through G-protein gating in smooth muscle cells from rabbit portal vein. 1994 (submitted)

  72. Yazawa K, Kameyama M: Mechanism of receptor-mediated modulation of the delayed outward potassium current in guinea-pig ventricular myocytes. J Physiol 421:135–150, 1990

    PubMed  Google Scholar 

  73. DiFrancesco D, Tromba C: Muscarinic control of the hyperpolarization-activated current (if) in rabbit sino-atrial node myocytes. J Physiol (London) 405:493–510, 1988

    Google Scholar 

  74. Ehara T, Ishihara K: Anion channels activated by adrenaline in cardiac myocytes. Nature 347:284–286, 1990

    PubMed  Google Scholar 

  75. Tareen FM, Ono A, Noma A, Ehara T: β-adrenergic and muscarinic regulation of the chloride current in guinea-pig ventricular cells. J Physiol 440: 225–241, 1991

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This review-type article was prepared by modifying an article published in a book by Sperelakiset al., 1994.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sperelakis, N., Xiong, Z., Haddad, G. et al. Regulation of slow calcium channels of myocardial cells and vascular smooth muscle cells by cyclic nucleotides and phosphorylation. Mol Cell Biochem 140, 103–117 (1994). https://doi.org/10.1007/BF00926749

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00926749

Key words

Navigation